当前位置:首页 - 行情中心 - 海昇药业(920656) - 财务分析 - 现金流量表

海昇药业

(920656)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金47,696,273.2226,047,046.76121,953,870.9892,161,862.25
  收到其他与经营活动有关的现金982,729.48363,280.8216,879,219.915,856,717.22
  经营活动现金流入小计48,679,002.726,410,327.58138,833,090.8998,018,579.47
  购买商品、接受劳务支付的现金23,942,331.9712,863,484.0856,358,653.0136,272,193.26
  支付给职工以及为职工支付的现金15,865,989.377,473,422.4532,108,308.5221,398,084.75
  支付的各项税费8,636,191.514,891,314.6410,621,251.6212,349,378.83
  支付其他与经营活动有关的现金3,715,583.422,233,122.7315,091,690.038,114,720.11
  经营活动现金流出小计52,160,096.2727,461,343.9114,179,903.1878,134,376.95
  经营活动产生的现金流量净额-3,481,093.57-1,051,016.3224,653,187.7119,884,202.52
二、投资活动产生的现金流量:
  收回投资收到的现金---845,250,000
  取得投资收益收到的现金2,713,798.711,573,001.464,877,691.2-
  收到的其他与投资活动有关的现金1,636,000,0001,048,400,0001,830,550,000-
  投资活动现金流入小计1,638,713,798.711,049,973,001.461,835,427,691.2845,250,000
  购建固定资产、无形资产和其他长期资产支付的现金7,164,144.728,460,216.0723,749,947.1617,089,644.78
  投资支付的现金---1,101,250,000
  支付其他与投资活动有关的现金1,791,000,0001,118,400,0001,830,550,000-
  投资活动现金流出小计1,798,164,144.721,126,860,216.071,854,299,947.161,118,339,644.78
  投资活动产生的现金流量净额-159,450,346.01-76,887,214.61-18,872,255.96-273,089,644.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金--367,150,000367,150,000
  取得借款收到的现金---19,698,100
  收到其他与筹资活动有关的现金--19,698,100-
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--386,848,100386,848,100
  分配股利、利润或偿付利息支付的现金20,000,000-40,000,00040,004,000
  支付其他与筹资活动有关的现金9,798,100-6,300,6008,171,600
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计29,798,100-46,300,60048,175,600
  筹资活动产生的现金流量净额平衡项目0-00
  筹资活动产生的现金流量净额-29,798,100-340,547,500338,672,500
四、汇率变动对现金及现金等价物的影响104,897.98141,1001,225,349.33627,887.52
五、现金及现金等价物净增加额-192,624,641.6-77,797,130.93347,553,781.0886,094,945.26
  加:期初现金及现金等价物余额446,644,080.49446,853,145.5199,090,299.4199,090,299.41
  期末现金及现金等价物余额254,019,438.89369,056,014.58446,644,080.49185,185,244.67
补充资料:
  净利润30,325,906.98-50,750,223.4-
  资产减值准备5,028.7-371,424.8-
  固定资产和投资性房地产折旧8,330,573.95-10,379,238.96-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧8,330,573.95-10,379,238.96-
  无形资产摊销414,674.46-691,864.68-
  长期待摊费用摊销88,225.02-168,020.6-
  财务费用-43,864.99--1,225,349.33-
  投资损失-2,713,798.71--4,877,691.2-
  递延所得税-132,367.94-51,153.37-
  其中:递延所得税资产减少-132,367.94-51,153.37-
  存货的减少-4,837,487.71-3,823,109.75-
  经营性应收项目的减少-13,277,196.6--35,838,322.45-
  经营性应付项目的增加-23,624,858.46-36,485.41-
  其他1,106,647.52-1,035,476.99-
  现金的期末余额254,019,438.89-446,644,080.49-
  减:现金的期初余额446,644,080.49-99,090,299.41-
  现金及现金等价物的净增加额-192,624,641.6-347,553,781.08-
公告日期2025-08-212025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑